Everolimus with reduced tacrolimus in liver transplantation

American Journal of Transplantation

Volumn 13, Issue 5, 2013, Pages 1373-1374

  De Simone, P ^a   Beckebaum, S ^b,c   Koneru, B ^d   Fung, J ^e   Saliba, F ^f  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ACUTE GRAFT REJECTION; DRUG EFFICACY; DRUG EXPOSURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LETTER; LIVER TRANSPLANTATION; MORTALITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

GRAFT SURVIVAL; HUMANS; LIVER TRANSPLANTATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL INSUFFICIENCY; TACROLIMUS;

EID: 84876948994     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12215     Document Type: Letter

References (6)

1. Rodríguez-Perálvarez M, Germani G, Darius R, et al. Tacrolimus exposure after liver transplantation in randomized controlled trials: Too much for too long. Am J Transplant 2013; 13: 1371-1372.
2. De Simone P, Nevens F, De Carlis L, et al. Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: A randomized controlled trial. Am J Transplant 2012; 12: 3008-3020.
3. Watt KD, Pedersen RA, Kremers WK, Heimbach JK, Charlton MR., Evolution of causes and risk factors for mortality post-liver transplant: Results of the NIDDK long-term follow-up study. Am J Transplant 2010; 10: 1420-1427.
4. Rodríguez-Perálvarez M, Germani G, Papastergiou V, et al. Early tacrolimus exposure after liver transplantation: Relationship with moderate/severe acute rejection and long-term outcome. J Hepatol 2013; 58: 262-270.
5. Boudjema K, Camus C, Saliba F, et al. Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: A randomized study. Am J Transplant 2011; 11: 965-976.
6. Neuberger JM, Mamelok RD, Neuhaus P, et al. Dealyed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: The "ReSpECT" study. Am J Transpl 2009; 9: 327-336.